202 related articles for article (PubMed ID: 23937345)
1. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.
Smits JA; Hofmann SG; Rosenfield D; DeBoer LB; Costa PT; Simon NM; O'Cleirigh C; Meuret AE; Marques L; Otto MW; Pollack MH
J Consult Clin Psychol; 2013 Dec; 81(6):1100-12. PubMed ID: 23937345
[TBL] [Abstract][Full Text] [Related]
2. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH
Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
Scheeringa MS; Weems CF
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
[TBL] [Abstract][Full Text] [Related]
4. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
Otto MW; Pollack MH; Dowd SM; Hofmann SG; Pearlson G; Szuhany KL; Gueorguieva R; Krystal JH; Simon NM; Tolin DF
Depress Anxiety; 2016 Aug; 33(8):737-45. PubMed ID: 27315514
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
6. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
[TBL] [Abstract][Full Text] [Related]
7. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.
Wilhelm S; Berman N; Small BJ; Porth R; Storch EA; Geller D
J Affect Disord; 2018 Dec; 241():454-460. PubMed ID: 30149332
[TBL] [Abstract][Full Text] [Related]
8. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
9. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
[TBL] [Abstract][Full Text] [Related]
10. Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
Zalta AK; Dowd S; Rosenfield D; Smits JA; Otto MW; Simon NM; Meuret AE; Marques L; Hofmann SG; Pollack MH
Depress Anxiety; 2013 Nov; 30(11):1114-20. PubMed ID: 24038728
[TBL] [Abstract][Full Text] [Related]
11. D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
Diminich ED; Dickerson F; Bello I; Cather C; Kingdon D; Rakhshan Rouhakhtar PJ; Hart KL; Li C; Troxel AB; Goff DC
Schizophr Res; 2020 Aug; 222():145-152. PubMed ID: 32591238
[TBL] [Abstract][Full Text] [Related]
12. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
[TBL] [Abstract][Full Text] [Related]
13. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases.
Kappelmann N; Suesse M; Steudte-Schmiedgen S; Kaldewaij R; Browning M; Michael T; Rinck M; Reinecke A
J Behav Ther Exp Psychiatry; 2020 Sep; 68():101546. PubMed ID: 31951819
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
Guastella AJ; Richardson R; Lovibond PF; Rapee RM; Gaston JE; Mitchell P; Dadds MR
Biol Psychiatry; 2008 Mar; 63(6):544-9. PubMed ID: 18179785
[TBL] [Abstract][Full Text] [Related]
15. Baseline Severity as a Moderator of the Waiting List-Controlled Association of Cognitive Behavioral Therapy With Symptom Change in Social Anxiety Disorder: A Systematic Review and Individual Patient Data Meta-analysis.
Scholten W; Seldenrijk A; Hoogendoorn A; Bosman R; Muntingh A; Karyotaki E; Andersson G; Berger T; Carlbring P; Furmark T; Bouchard S; Goldin P; Kampmann I; Morina N; Kocovski N; Leibing E; Leichsenring F; Stolz T; van Balkom A; Batelaan N
JAMA Psychiatry; 2023 Aug; 80(8):822-831. PubMed ID: 37256597
[TBL] [Abstract][Full Text] [Related]
16. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
Roque AD; Rosenfield D; Smits JAJ; Simon N; Otto MW; Marques L; Pollack MH; Hofmann SG; Meuret AE
J Anxiety Disord; 2018 Jan; 53():85-90. PubMed ID: 29227845
[TBL] [Abstract][Full Text] [Related]
17. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
[TBL] [Abstract][Full Text] [Related]
18. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
[TBL] [Abstract][Full Text] [Related]
19. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]